Stock Events

Stock Events

Search...

Madrigal Pharmaceuticals (MDGL) Q2 2025 Earnings

1MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-7.54

-5.93

-4.32

-2.71

Details

Expected EPS

-3.748533

Actual EPS

-3.32

Surprise EPS

0.43

Surprise Percent

+11.43%

Description

Madrigal Pharmaceuticals (MDGL) has reported earnings of -3.32 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.